Study to Establish Image Interpretation Criteria for 18F Fluciclovine PET in Detecting Recurrent Brain Metastases (PURSUE)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Eugene Teoh, MD
Blue Earth Diagnostics
Study Director - Rupesh Kotecha, MD
Miami Cancer Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- John Wayne Cancer Institute at Providence St. John'S Health Center
Santa Monica, California, United States
- Yale School of Medicine
New Haven, Connecticut, United States
- Miami Cancer Institute
Miami, Florida, United States
- Ochsner Clinic Foundation
New Orleans, Louisiana, United States
- Washington University School of Medicine Center for Clinical Imaging Research
St Louis, Missouri, United States
- Nyu Langone Health
New York, New York, United States
- University Hospital Cleveland
Cleveland, Ohio, United States
- University of Pennsylvania Health System
Philadelphia, Pennsylvania, United States
- Center for Quantitative Cancer Imaging at Huntsman Cancer Institute
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2020
- Primary completion
- 31 Dec 2021
- Completion
- 31 Dec 2021
- Last update posted
- 20 Jul 2025
- Registered enrollment
- 23
- Registry id
- NCT04410367
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.